CTOs on the Move


 
ALZYN is a development stage company pursuing a unique approach to retard the progress of Alzheimer`s Disease. The science originated at the Florida State University`s College of Medicine.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.alzyn.com
  • 2401 2nd Street N
    Saint Petersburg, FL USA 33704
  • Phone: N/A

Executives

Name Title Contact Details

Similar Companies

Twin County Airport

Twin County Airport is a Hillsville, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aid and Assist at Home

Aid and Assist at Home, Inc. is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Christ Community Health Services Augusta

Christ Community Health Services Augusta is a non-profit organization that provides affordable, quality primary health and dental care for the uninsured, the under insured and the under served of Augusta, Georgia.

Shore Medical Center

Shore Medical Center operates as a hospital facility. It offers anesthesiology, balance, blood bank, cancer, cardiovascular, critical, diabetes education, endoscopy, hospitalist, kidney disease, laboratory, maternal-fetal medicine, neurosciences, nutrition, outpatient testing, palliative, pulmonary diagnostic, radiology and diagnostic imaging, rehabilitation, respiratory, sleep medicine, social, spine and orthopedic, stroke, surgical, urgent, wound and hyperbaric medicine, vascular, neurological, emergency, and maternity and pediatric health care services. Shore Medical Center was formerly known as Shore Medical Center. The company is based in Somers Point, New Jersey. Shore Medical Center operates as a subsidiary of Shore Health Systems Inc.

ASCENDIS PHARMA

Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.